Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0017 | 0 | 0.5 |
Echinococcus multilocularis | microsomal glutathione S transferase 3 | 0.0592 | 1 | 0.5 |
Leishmania major | cytochrome p450-like protein | 0.0017 | 0 | 0.5 |
Schistosoma mansoni | membrane associated proteins in eicosanoid and glutathione metabolism family member | 0.0592 | 1 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0029 | 0.0198 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0017 | 0 | 0.5 |
Toxoplasma gondii | MAPEG family protein | 0.0592 | 1 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0017 | 0 | 0.5 |
Schistosoma mansoni | microsomal glutathione s-transferase | 0.0592 | 1 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0029 | 0.0198 | 1 |
Trypanosoma brucei | cytochrome P450, putative | 0.0017 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.